Historique de carrière de Gregory M. Torre
Anciens postes connus de Gregory M. Torre
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Directeur/Membre du Conseil | 29/12/2017 | 27/04/2018 |
| Directeur Technique/Scientifique/R&D | 29/12/2017 | 27/04/2018 | |
| Conseiller Juridique Général | 29/12/2017 | 27/04/2018 | |
| NPS PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/02/2006 | 31/07/2007 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Conseiller Juridique Général | 22/12/2010 | - |
| Corporate Officer/Principal | - | - |
Formation de Gregory M. Torre
| St. John's University | Doctorate Degree |
| Brooklyn Law School | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| General Counsel | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
- Bourse
- Insiders
- Gregory M. Torre
- Expérience
